✦ LIBER ✦

Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia

✍ Scribed by Nidal M. Almasri; Ricardo E. Duque; Jose Iturraspe; Eric Everett; Raul C. Braylan

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 461 KB
Volume: 40
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830400404

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor necrosis factor modulates CD 20 ex

Tumor necrosis factor modulates CD 20 expression on cells from chronic lymphocytic leukemia: A new role for TNF alpha?

✍ S. Sivaraman; C.G. Deshpande; R. Ranganathan; X. Huang; A. Jajeh; T. O'brien; R. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

Tumor necrosis factor alpha (TNF␣) is a pleiotropic cytokine that is constitutively produced by leukemic cells in B Chronic Lymphocytic Leukemia (B-CLL). It has been shown to have autocrine and paracrine functions in normal B cells and in B lymphoproliferative diseases. This study was conducted to d

A robust ratio metric method for analysi

A robust ratio metric method for analysis of Zap-70 expression in chronic lymphocytic leukemia (CLL)

✍ Antony C. Bakke; Zoe Purtzer; Jose Leis; James Huang 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB

The New Zealand black mouse as a model f

The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia

✍ Erica Salerno; Yao Yuan; Brian J. Scaglione; Gerald Marti; Alexander Jankovic; F 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 660 KB

Suprabasal expression of Ki-67 antigen a

Suprabasal expression of Ki-67 antigen as a marker for the presence and severity of oral epithelial dysplasia

✍ Miguel A. Gonzalez-Moles; Isabel Ruiz-Avila; Alberto Rodriguez-Archilla; Ildefon 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

Background. Suprabasal expression of Ki-67 is assessed as a marker for oral dysplasia. The study involved nonneoplastic epithelium adjacent to 74 oral squamous cell carcinomas. Methods. An immunohistochemical technique was carried out (peroxidase-antiperoxidase) with the monoclonal antibody MIB-1.

Expression of CD134 (0X-40) on T cells d

Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease

✍ L.S. Lamb Jr; S.A. Abhyankar; L. Hazlett; W. O'Neal; R.S. Folk; S. Vogt; R.S. Pa 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 1 views

## CD134 (OX-40 ) is an activation-associated antigen which functions as a costimulatory receptor for CD4؉ T cells. In order to determine the expression of CD134 during immune recovery following allogeneic bone marrow transplantation (BMT), we measured its expression on T cells and T cell subsets